Eli Lilly announced a partnership with Walmart that will make the retailer the first to offer in-store pharmacy pickup of single-dose vials of its weight-loss medication Zepbound for self-pay customers.

Beginning in mid-November, Walmart’s 4,600 pharmacies will offer discounted prescriptions of Zepbound. Eli Lilly said customers will pay $349 for a 2.5-milligram dose, while higher doses will cost $499.

The company said the prices represent more than a 50% discount compared to the list price of other GLP-1 drugs for obesity. The discount is available to anyone with a valid prescription, regardless of insurance status.

Many insurers have declined to cover weight-loss medications such as Zepbound, citing high costs. Lilly said 35% of new Zepbound prescriptions are filled through its LillyD

See Full Page